Overview of Liver function in outpatient using cholesterol reducing drug Rosuvastatin
- At: 2012 FIP Congress in Amsterdam (the Netherlands)
- Type: Poster
- By: CHEN, Yu-Yu (Taipei, China Taiwan)
- Co-author(s): Huang, C.M. (, Taipei, China Taiwan)
Chang, H. (Cheng Hsing General Hospital, Taipei, China Taiwan)
? Background information: HMG-CoA is a reductase inhibitor (also known as the statin class) which effectively reduces LDL-C Drug ; rosuvastatin sees the largest use and has the strongest effect of these types of drugs.? Aims? Retrospective analysis will be conducted in clinical cases of monitoring liver function in hospital use of Rosuvastatin?.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.